Nov. 4, 2022 — The U.S. Food and Drug Administration (FDA) is recommending health care providers discuss alternative options for Magnetic Resonance Imaging (MRI)-guided breast biopsy procedures with patients if a facility is unable to perform the biopsy due to a shortage of Philips Invivo MRI breast biopsy grid plates and other Philips Invivo MRI disposables.
The FDA Recommends That Health Care Providers:
· Discuss options with patients if MRI breast biopsy grid plates or other MRI coil disposables are not available at their facility.